

08 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/08/3269968/0/en/Incyclix-Bio-Raises-Additional-5-Million-in-Series-B-Financing-to-Advance-Clinical-Trial-of-INX-315-in-Patients-with-CDK4-6-Inhibitor-Resistant-ER-HER2-Breast-Cancer-or-CCNE1-Ampli.html